Haemonetics HAE Cash Flow Statement
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| —— | $44.74M+15.7% | $38.68M+13.7% | $34.03M-41.3% | $57.98M+54.6% | ||
| $27.32M-0.2% | $27.39M-3.1% | $28.26M-1.7% | $28.76M+1.9% | $28.21M-2.8% | ||
| $9.13M+17.0% | $7.8M+2.8% | $7.59M-18.5% | $9.31M+34.2% | $6.94M-15.5% | ||
| $70.94M-24.2% | $93.56M-16.0% | $111.32M+540% | $17.4M-85.1% | $116.56M+166% | ||
| $17.66M+178% | $6.35M+26.6% | $5.02M+33.6% | $3.75M-76.0% | $15.64M+83.0% | ||
| $60.18M— | $0— | $0— | $0— | —— | ||
| -$86.61M-194% | -$29.47M+3.3% | -$30.47M+7.7% | -$33M— | —— | ||
| $100M— | —— | —— | —— | $150M— | ||
| $0— | $0— | $0— | $0— | —— | ||
| -$4.69M-400% | $1.56M+0.1% | $1.56M-0.1% | $1.56M0.0% | $1.56M+0.1% | ||
| -$101.5M— | $0+100% | -$76.55M-3,035% | -$2.44M— | —— | ||
| -$117.93M-276% | $66.94M— | $0+100% | -$13.87M— | —— | ||
| $53.28M-38.9% | $87.22M-18.0% | $106.31M+679% | $13.64M-86.5% | $100.91M+187% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Haemonetics's cash flow data come from?
- Every line is extracted from Haemonetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.